newsfilter
← Latest News
Business Wire·

Enanta Pharmaceuticals to Appeal Ruling Related to '953 Patent Infringement Lawsuit

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that the United States District